F. Cambien
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Hormonal Regulation and Hypertension 1
-
- Renin-Angiotensin System Studies 2
-
- Lipoproteins and Cardiovascular Health 3
-
- Computational Drug Discovery Methods 2
-
- Receptor Mechanisms and Signaling 2
-
- Healthcare Systems and Practices 2
-
- Blood properties and coagulation 1
- Co-authors
- Dominique ArveilerLaure LecerfPierre DucimetièreViviane NicaudA. EvansG. LucF. KeePhilippe Amouyel
- Journals
- Journal of Lipid Research (1 paper)Diabetes & Metabolism (1 paper)Journal of the American Society of Nephrology (1 paper)
- Partner nations
- FranceUnited KingdomSweden
In The Last Decade
F. Cambien
15 papers receiving 476 citations
Peers
Comparison fields: 5 of 69
- Endocrinology, Diabetes and Metabolism 271
- Cardiology and Cardiovascular Medicine 253
- Pharmacology 82
- Physiology 93
- Surgery 139
Countries citing papers authored by F. Cambien
This map shows the geographic impact of F. Cambien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Cambien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Cambien more than expected).
Fields of papers citing papers by F. Cambien
This network shows the impact of papers produced by F. Cambien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Cambien. The network helps show where F. Cambien may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. Cambien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 1 | |
| 2 | The canosinase gene (CNDP1) is not a protection factor of diabetic nephropathy in type 1 diabetics | 2006 | 1 |
| 3 | 2003 | 2 | |
| 4 | 1999 | 94 | |
| 5 | [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors]. | 1998 | 6 |
| 6 | 1997 | 1 | |
| 7 | 1996 | 103 | |
| 8 | The insertion/deletion polymorphism in the angiotensin I-converting enzyme gene predicts the progression of diabetic nephropathy during ACE inhibition in insulin dependent diabetic patients | 1995 | 9 |
| 9 | The effect of diet on lipid, apoprotein and lipoparticle variation in the ECTIM study in Belfast. | 1995 | 2 |
| 10 | ACE GENE POLUMORPHISM, DIABETIC NEPHROPATHY, AND CORONARY HEART DISEASE IN IDDM PATIENTS | 1994 | 1 |
| 11 | 1993 | 211 | |
| 12 | 1993 | 36 | |
| 13 | Combined effects of sex and hypertension on the geometrical design of large arteries. Sexual differences in normal and hypertensive forearm arteries. | 1987 | 3 |
| 14 | [Mortality in cerebrovascular diseases and alcoholism in France]. | 1987 | 2 |
| 15 | [Epidemiologic characteristics of coronary disease in France]. | 1981 | 20 |
| 16 | Familial history of coronary heart diseases and high blood pressure in relation to the prevalence of risk factors, and the incidence of coronary heart diseases. The Paris Prospective Study. | 1980 | 1 |
About F. Cambien
F. Cambien is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Cardiology and Cardiovascular Medicine, Computational Theory and Mathematics and Pharmacology, having authored 16 papers that have together received 493 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Computational Drug Discovery Methods (2 papers), Receptor Mechanisms and Signaling (2 papers), Renin-Angiotensin System Studies (2 papers), Healthcare Systems and Practices (2 papers), Hormonal Regulation and Hypertension (1 paper) and Blood properties and coagulation (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (271 citations), Cardiology and Cardiovascular Medicine (253 citations), Pharmacology (82 citations), Physiology (93 citations) and Surgery (139 citations). F. Cambien has collaborated with scholars based in France, United Kingdom and Sweden. Frequent co-authors include Dominique Arveiler, Laure Lecerf, Pierre Ducimetière, Viviane Nicaud, A. Evans, G. Luc, F. Kee, Philippe Amouyel, Laurence Tiret and Odette Poirier. Their work appears in journals such as Journal of Lipid Research, Diabetes & Metabolism, Journal of the American Society of Nephrology, Diabetes and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.